文献速递慢性肾脏病遗传性与小管间质肾病血液净化与透析

外显子测序在以色列肾衰竭儿童中的诊断价值

Diagnostic Utility of Exome Sequencing Among Israeli Children With Kidney Failure.
PubMed 文献 · Kidney Int Rep · 2023-07-31

以色列全国多中心前瞻性研究纳入79例透析儿童(约占全国88%),外显子测序在36/79(45%)中检出遗传病因,最常见为先天性肾脏和尿路畸形相关基因(占单基因病因28%),阿拉伯裔及近亲婚配者诊断率更高,75%(27/36)遗传诊断可能影响临床管理。

要点

  • 儿童透析肾衰竭外显子测序遗传诊断率为45%(36/79)。
  • 先天性肾脏和尿路畸形相关基因占单基因病因28%,居首位。
  • 阿拉伯裔vs犹太裔诊断率55%vs29%,近亲vs非近亲63%vs29%。

核心结论

  • 在无偏倚的以色列全国透析治疗儿童肾衰竭队列中,外显子测序遗传诊断率为45%,且常可影响临床决策。

研究设计与样本

  • 以色列全国6个儿童透析中心多中心前瞻性研究,2019–2022年招募约88%(n=79)透析儿童,行外显子测序并评估遗传诊断率。

主要发现

  • 79例中36例(45%)检出遗传病因。
  • 诊断变异最常见亚组为先天性肾脏和尿路畸形相关基因(如EYA1、HNF1B、PAX2、COL4A1、NFIA),合计解释全部单基因病因的28%。
  • 其后依次为肾囊性纤毛病相关基因(如NPHP1、NPHP4、PKHD1、BBS9)、激素抵抗型肾病综合征相关基因(如LAGE3、NPHS1、NPHS2、LMX1B、SMARCAL1)及肾小管病相关基因(如CTNS、AQP2)。
  • 遗传诊断率阿拉伯裔vs犹太裔为55%vs29%,近亲婚配家庭vs非近亲婚配家庭为63%vs29%。
  • 36例遗传诊断中5例(14%)分子诊断与测序前诊断不一致;遗传诊断对36例中27例(75%)的临床管理有潜在影响。

临床怎么用

  • 对儿童透析肾衰竭人群可行外显子测序以检出遗传病因。
  • 遗传诊断在部分病例中与测序前诊断不一致,并可潜在影响临床管理。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Genetic etiologies are estimated to account for a large portion of chronic kidney diseases (CKD) in children. However, data are lacking regarding the true prevalence of monogenic etiologies stemming from an unselected population screen of children with advanced CKD. METHODS: We conducted a national multicenter prospective study of all Israeli pediatric dialysis units to provide comprehensive "real-world" evidence for the genetic basis of childhood kidney failure in Israel. We performed exome sequencing and assessed the genetic diagnostic yield. RESULTS: Between 2019 and 2022, we recruited approximately 88% (n = 79) of the children on dialysis from all 6 Israeli pediatric dialysis units. We identified genetic etiologies in 36 of 79 (45%) participants. The most common subgroup of diagnostic variants was in congenital anomalies of the kidney and urinary tract causing genes (e.g., EYA1, HNF1B, PAX2, COL4A1, and NFIA) which together explain 28% of all monogenic etiologies. This was followed by mutations in genes causing renal cystic ciliopathies (e.g., NPHP1, NPHP4, PKHD1, and BBS9), steroid-resistant nephrotic syndrome (e.g., LAGE3, NPHS1, NPHS2, LMX1B, and SMARCAL1) and tubulopathies (e.g., CTNS and AQP2). The genetic diagnostic yield was higher among Arabs compared to Jewish individuals (55% vs. 29%) and in children from consanguineous compared to nonconsanguineous families (63% vs. 29%). In 5 participants (14%) with genetic diagnoses, the molecular diagnosis did not correspond with the pre-exome diagnosis. Genetic diagnosis has a potential influence on clinical management in 27 of 36 participants (75%). CONCLUSION: Exome sequencing in an unbiased Israeli nationwide dialysis-treated kidney failure pediatric cohort resulted in a genetic diagnostic yield of 45% and can often affect clinical decision making.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ben-Moshe Y, Shlomovitz O, Atias-Varon D, et al. Diagnostic Utility of Exome Sequencing Among Israeli Children With Kidney Failure. Kidney Int Rep. 2023. PMID: 37850020. doi:10.1016/j.ekir.2023.07.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。